Emmaus Life Sciences, Inc. (OTCQX: EMMA), today reported financial results for the three and six months ended June 30, 2022 and provided a business update.
Read More
Life Sciences Investor Forum: Company Executives Present Live June 23rd
Read More
Emmaus Life Sciences, Inc. (OTCQX: EMMA) today reported financial results for the three months ended March 31, 2022 and provided a business update.
Read More
Emmaus Life Sciences, Inc. today announced participation in the Q2 Investor Summit and the H.C Wainwright Global Investment Conference.
Read More
Platform Providers Will Handle On-line Prescribing, Dispensing and Delivery of Endari
Read More